Abstract
Mitogenic signals initiated at the plasma membrane are transmitted to the nucleus through an intricate signalling network. We identified the protooncoprotein Cot as a new component of mitogenic signalling cascades, which activates both the classic cytoplasmic cascade and the SAPK stress pathway. Wildtype and activated Cot phosphorylate and activate MEK-1 and SEK-1 in vitro. These findings are consistent with the sequence homology between Cot and the rat gene Tpl-2. Expression of oncogenic Cot in 293, NIH3T3 and PC12 cells leads to in vivo phosphorylation of endogenous c-Jun and Erk-1/2 suggesting that the serine/threonine kinase Cot functions beside c-Raf-1 and Mos as a direct activator of MEK-1. Furthermore, we have examined the biological effects of Cot on the phenotype of fibroblastic and neuronal cells. In order to test a potential c-Raf-1 dependency of Cot transformation, the effect of oncogenic Cot on Raf revertant CHP25 cells was determined. Cot could restore the transformed phenotype indicating that Cot transformation is not dependent on active c-Raf-1 and that Cot is not a target for the putative Raf inhibitor, which is presumably active in the revertant cell line. Expression of oncogenic versions of Raf as well as v-Mos leads to differentiation of PC12 cells. Cot also induces neurite outgrowth of PC12 cells. These data are consistent with the role of Cot in the classic mitogenic cascade and suggest that the simultaneously activated JNK/SAPK stress pathway has no antagonistic effects in this context.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- Cot:
-
cancer osaka thyroid
- ERK:
-
extracellular signal regulated kinase
- MEK:
-
MAPK/ERK kinase
- MAPK:
-
mitogen activated protein kinase
- MKK:
-
MAPK kinase
- SAPK:
-
stress activated protein kinase
- JNK:
-
c-Jun N-terminal kinase
- PSK:
-
protein serine kinase
- PTK:
-
protein tyrosine kinase
- Tpl-2:
-
tumor progression locus 2
- SHOK:
-
syrian hamster Osaka kanazawa
- HA:
-
hemaglutinin
- MOI:
-
multiplicity of infection
- NGF:
-
nerve growth factor
References
Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Ashworth A, Marshall CJ and Cowley S. . 1994 EMBO J. 13: 1610–1619.
Aoki M, Hamada F, Sugimoto T, Sumida S, Akiyama T and Toyoshima K. . 1993 J. Biol. Chem. 268: 22723–22732.
Avruch J, Zhang XF and Kyriakis JM. . 1994 Trends Biochem. Sci. 19: 279–283.
Blenis J. . 1993 Proc. Natl. Acad. Sci. USA 90: 5889–5892.
Bruder JT, Heidecker G and Rapp UR. . 1992 Genes & Dev. 6: 545–556.
Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, Rapp UR and Cooper GM. . 1997 Mol. Cell. Biol. 17: 732–741.
Cano E and Mahadevan LC. . 1995 Trends Biochem. Sci. 20: 117–122.
Chen C and Okayama H. . 1987 Mol. Cell. Biol. 7: 2745–2752.
Crews CM and Erikson RL. . 1992 Proc. Natl. Acad. Sci. USA 89: 8205–8209.
Daum G, Eisenmann-Tappe I, Fries HW, Troppmair J and Rapp UR. . 1994 Trends Biochem. Sci. 19: 474–480.
Davis RJ. . 1994 Trends Biochem. Sci. 19: 470–473.
Fanger GR. Gerwin P, Widmann C, Jarpe MB and Johnson GL. . 1997 Curr. Opin. Gen. Dev. 7: 67–74.
Field J, Nikawa J, Broek D, MacDonald B, Rodgers L, Wilson IA, Lerner RA and Wigler M. . 1988 Mol. Cell. Biol. 8: 2159–2165.
Han J, Lee JD, Bibbs L and Ulevitch RJ. . 1994 Science 265: 808–811.
Heidecker G, Cleveland JL, Beck T, Huleihel M, Kolch W, Storm SM and Rapp UR. . (1989) Genes and Signal Transduction in Multistage Carcinogenesis. Colburn NH (ed.). Marcel Dekker, Inc.: New York and Basel pp. 339–374.
Hibi M, Lin A, Smeal T, Minden A and Karin M. . 1993 Genes & Dev. 7: 2135–2148.
Kerkhoff E and Rapp UR. . 1997 Mol. Cell. Biol. 17: 2576–2586.
Kolch W, Heidecker G, Troppmair J, Yanagihara K, Bassin RH and Rapp UR. . 1993 Oncogene 8: 361–370.
Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J and Woodgett JR. . 1994 Nature 369: 156–160.
Leppä S, Saffrich R, Ansorge W and Bohmann D. . 1998 EMBO J. 17: 4404–4413.
Ludwig S, Engel K, Hoffmeyer A, Sithanandam G, Neufeld B, Palm D, Gaestel M and Rapp UR. . 1996 Mol. Cell. Biol. 16: 6687–6697.
Makris A, Patriotis C, Bear SE and Tsichlis PN. . 1993 J. Virol. 67: 4283–4289.
McCarthy SA, Samuels ML, Pritchard CA, Abraham JA and McMahon M. . 1995 Genes & Dev. 9: 1953–1964.
Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL and Karin M. . 1994 Science 266: 1719–1723.
Miyoshi J, Higashi T, Mukai H, Ohucji T and Kakunaga T. . 1991 Mol. Cell. Biol. 11: 4088–4096.
Morrison DK and Cutler RE. . 1997 Curr. Opin. Cell. Biol. 9: 174–179.
Patriotis C, Makris A, Bear SE and Tsichlis PN. . 1993 Proc. Natl. Acad. Sci. USA 90: 2251–2255.
Patriotis C, Makris A, Chernoff J and Tsichlis PN. . 1994 Proc. Natl. Acad. Sci. USA 91: 9755–9759.
Rapp UR. . 1991 Oncogene 6: 495–500.
Rapp UR, Bruder JT and Troppmair J. . 1994 The fos and jun families of transcription factors. Angel PE and Herrlich PA (eds).. CRC Press: USA pp. 221–247.
Rapp UR, Cleveland JL, Bonner TI and Sorm SM. . 1988a) Handbook of oncogenes. Reddy P, et al. (eds). Elsevier Publishing: Amsterdam pp.213–253.
Rapp UR, Goldsborough MD, Mark GE, Bonner TI, Groffen J, Reynolds FH and Stephenson JR. . 1983b Proc. Natl. Acad. Sci. USA 80: 4218–4222.
Rapp UR, Heidecker G, Huleihel M, Cleveland JL, Choi WC, Pawson T, Ihle JN and Anderson WB. . 1988b Cold Spring Harbor Symp. Quanti. Biol. 53: 173–184.
Rapp UR, Reynolds FH and Stephenson JR. . 1983a J. Virol. 45: 914–924.
Rapp UR and Todaro GJ. . 1978 Proc. Natl. Acad. Sci. USA 75: 2468–2472.
Robbins DJ, Zhen E, Owaki H, Vanderbilt CA, Ebert D, Geppert TD and Cobb MH. . 1993 J. Biol. Chem. 268: 5097–5106.
Robinson MJ and Cobb MH. . 1997 Curr. Opin. Cell. Biol. 9: 180–186.
Salmerón A, Ahmad TB, Carlile GW, Pappin D, Narsimhan RP and Ley SC. . 1996 EMBO J. 15: 817–826.
Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM and Zon LI. . 1994 Nature 372: 794–798.
Slupsky JR, Weber CK, Ludwig S, Rapp UR. . (1998) Cell Growth and Oncogenesis. Bannasch P, Kanduc D, Papa S and Tager JM (eds).. Birkhäuser Verlag: Basel, Switzerland pp.75–95.
Troppmair J, Bruder JT, Munoz H, Lloyd PA, Kyriakis J, Banerjee P, Avruch J and Rapp UR. . 1994 J. Biol. Chem. 269: 7030–7035.
Wixler V, Smola U, Schuler M and Rapp UR. . 1996 FEBS Lett. 385: 131–137.
Woodgett JR, Avruch J and Kyriakis J. . 1996 Cancer Surv. 27: 127–138.
Xia Z, Dickens M, Raingeud J, Davis RJ and Greenberg ME. . 1995 Science 270: 1326–1331.
Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR and Templeton DJ. . 1994 Nature 372: 798–800.
Acknowledgements
We are grateful to Jun Myoshi for kindly providing different cot expression plasmids and Cot antibody. We further thank Silvia Pfränger for excellent photographic reproduction, Viktor Wixler, Barbara Bauer and Manuela Schuler for technical assistance, and Carsten Hagemann and Bruce Jordan for critical reading of the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hagemann, D., Troppmair, J. & Rapp, U. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells. Oncogene 18, 1391–1400 (1999). https://doi.org/10.1038/sj.onc.1202431
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202431
Keywords
This article is cited by
-
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas
Nature Medicine (2019)
-
Mek2
AfCS-Nature Molecule Pages (2005)
-
Mek1
AfCS-Nature Molecule Pages (2005)
-
Independent control of cell survival by Raf-1 and Bcl-2 at the mitochondria
Oncogene (2001)
-
Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade
Nature Immunology (2001)